Gamgee

Infectious Disease Therapeutics · Health Care

Overview

Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets and register your interest.

Funding and backers

Backers
1
Y Combinator
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 2026 Went through Y Combinator Apr 20, 2021 Partnership Gamgee and the Hebrew University Partner on the Development of Pioneering Machine Learning Algorithms to Protect Smart Homes and IoT · PRNewswire
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Genvax TechnologiesVenture round $3.4M · 2 yr ago · Founded 2021 · 11-50 employees
Genvax Technologies is an animal vaccine company developing next-generation mRNA + nanoparticle vaccines from Ames, Iowa. Our mission is to…
MalarVxConvertible Note $125k · 3 mo ago · 11-50 employees
THE COMPANY - MALARVX MalarVx Inc. is a biopharmaceutical company focused on developing an effective malaria vaccine.
SpyBiotech11-50 employees
SpyBiotech is a clinical stage biotechnology company with novel vaccine platform technologies to target infectious diseases, cancer and…
TareBio develops vaccines for cancer and infectious diseases by decoding immune responses to engineer targeted antigens.
Curevo Vaccine51-200 employees
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…
Abogen BiosciencesFounded 2019 · 13 roles
Abogen Biosciences is a Chinese clinical-stage biopharmaceutical company developing messenger RNA (mRNA) medicines with its own mRNA and…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Y CombinatorVia a fund
6310 portfolio companies

News

News markets.businessinsider.com 3 months ago
One Dog
A Media Snippet accompanying this announcement is available by clicking on this link.SYDNEY, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Rosie was given o...
Read more
Report
News ycombinator 3 months ago
Gamgee: Curing cancer. Starting with dogs. Y Combinator
Curing cancer. Starting with dogs. Founded in 2026 by Paul Conyngham, Gamgee has 2 employees based in San Francisco.
Read more
Report
News abcnews 5 months ago
This dog's cancer treatment 'excited' the US health boss but humans face hurdles
Rosie the dog had her tumours treated by an mRNA vaccine developed with the help of artificial intelligence. Her owner had decided to explore treatment options using AI chatbots.
Read more
Report
News TechRadar 7 months ago
Someone used ChatGPT to make a custom mRNA vaccine for his dog
The world is changing right now
Read more
Report
News Geo News 8 months ago
One man, his dog, and ChatGPT: Australia
HONG KONG: Desperate to help his sick dog, one Australian man went down the ultimate ChatGPT research hole, using artificial intelligence to design a personalised experimental treatment and finding top scientists to administer it.Paul...
Read more
Report
News CNBCTV18 8 months ago
Australian man uses ChatGPT to fight dog's cancer; Sam Altman calls it 'amazing story' - CNBC TV18
Paul Conyngham uses ChatGPT and AlphaFold to create a personalised mRNA cancer vaccine for his dog, impressing Sam Altman and hinting at a new AI health venture.
Read more
Report
News The Conversation 8 months ago
A man used AI to help make a cancer vaccine for his dog - an oncologist urges caution
One dog, one vaccine, one data point. The story of Rosie is fascinating - but it is not yet evidence that AI can beat cancer.
Read more
Report
News Reason Magazine 8 months ago
Man successfully designs mRNA vaccine to treat his dog's cancer
Paul Conyngham's 8-year-old rescue dog had a fatal skin cancer. He turned to AI to see if he could create a personalized anti-cancer vaccine.
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco United States
HQ